More than 136,000 Cubans who suffer from rheumatoid arthritis (RA), an irreversible chronic disease that erodes cartilage and bones and mainly affects women, will get to benefit from the mass production and application of the biotechnological product Jusvinza (CIGB-814/258), an immunoregulatory peptide for the treatment of this disease and hyperinflammation.

An 88 % of the Cuban population completed the vaccination scheme against COVID-19, with the national immunogens Soberana 02, Soberana Plus and Abdala.

 Cuba studied a total of 12,576 samples for surveillance during the day, resulting positive 1,018 for 8.1% of positivity. The country accumulates 12, 813,909 samples taken and 1, 055,927 positive (8.2%).

The Mental Health Program in eastern Santiago de Cuba province reported advancement in 2021 in terms of the psychological assistance and care of the local population, said program coordinator Yamilka Rodriguez.

 The Cuban COVID-19 vaccines are the result of the long history of the country’s bio-pharmaceutical industry, said Vicente Verez Bencomo, general director of the Havan-based “Finlay” Vaccines Institute.

At the end of February 5, 34, 551,520 doses of the Cuban vaccines Soberana 02, Soberana Plus and Abdala had been administered in the country, the Ministry of Public Health ( MINSAP by its Spanish acronym) reported today.

The BioHabana 2022 Congress, organized by the Group of the Biotechnological and Pharmaceutical Industries of Cuba (BioCubaFarma) as an opportunity to create alliances that allow a greater impact on public health, will be held at the Havana Convention Center April 25-29.

 The utmost care of grandparents by their families and themselves should be a priority in these days of pandemic, Francisco Duran Garcia, national director of epidemiology of the Cuban public health ministry, said today.

Cuba studied a total of 14,703 samples for surveillance during the day, with 1,349 positive for 9.2% positivity. The country accumulates 12, 801,333 samples taken and 1,054,909 positive (8.2%).

The Ministry of Public Health (MINSAP) reported today that 34,394,469 doses of the Cuban COVID-19 vaccines Soberana 02, Soberana Plus and Abdala have been administered in the country.

Cuba reported today 1,434 new COVID-19 cases, 2,721 hospital discharges and seven fatalities.

Over the years, treating cancer has been a priority for the Cuban health system, and not less so in times of the COVID-19 pandemic despite the limitations imposed by both the virus and the tightening of the U.S. blockade.

A total of 34, 345,875 doses of the Cuban anti-COVID-19 Soberana 02, Soberana Plus and Abdala vaccines have been administered in Cuba as of February 1, the Ministry of Public Health ( MINSAP by its Spanish acronym) reported today.

Cuba studied a total of 18,117 samples to detect new cases of COVID 19, with 1,546 resulting positive for 8.5% positivity. The country accumulates 12, 733,864 samples taken and 1,049,406 positive (8.2%).